STEVEN C QUAY
CIK 1008227 · President & CEO · last filed 2026-01-30
STEVEN C QUAY is a President & CEO who has filed 32 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for ATOS, was dated Jan 30, 2026. Across all open-market trades the lifetime net is −$431.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $59.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$59.13M
3
32
-$431.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATOS | President & CEO | 367,826 | $2.46 | $904.9K | -$7.7K | 21 | 2026-01-30 |
| MRNA | Chairman and CSO | 1,166,669 | $49.91 | $58.23M | $0 | 2 | 2009-03-20 |
| Adhera Therapeutics, Inc. (NSTK) Delisted | Chairman and CEO | 434,624 | — | — | -$424.0K | 9 | 2008-04-02 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-30 | ATOS | Grant (A) | +331,674 | $0 | EDGAR |
| 2026-01-22 | ATOS | Grant (A) | +325,203 | $0 | EDGAR |
| 2025-05-22 | ATOS | Buy (P) | +11,239 | $9.9K | EDGAR |
| 2025-05-16 | ATOS | Grant (A) | — | $0 | EDGAR |
| 2024-07-01 | ATOS | Grant (A) | — | $0 | EDGAR |
| 2023-03-06 | ATOS | Grant (A) | — | $0 | EDGAR |
| 2022-02-28 | ATOS | Grant (A) | — | $0 | EDGAR |
| 2021-05-18 | ATOS | Grant (A) | — | $0 | EDGAR |
| 2021-05-18 | ATOS | Grant (A) | — | $0 | EDGAR |
| 2020-04-13 | ATOS | Grant (A) | — | $0 | EDGAR |